When to Order Imaging for Management of Acute Pulmonary Embolism: ACR Appropriateness Decoded
When to Order Interventions for Management of Acute Pulmonary Embolism: ACR Appropriateness Decoded
It’s 11 p.m. in the emergency department, and you have a patient with a confirmed massive pulmonary embolism (PE) on CT angiography. Their blood pressure is dropping, and you need to decide on the next step in management—fast. Do you initiate systemic thrombolysis, call interventional radiology for catheter-directed therapy, or consult cardiothoracic surgery for an embolectomy? The choice depends critically on the patient’s hemodynamic stability, right heart function, and contraindications. This guide decodes the American College of Radiology (ACR) Appropriateness Criteria for managing acute PE, providing a clear framework for these high-stakes decisions based on the latest evidence-based guidelines from the ACR Interventional Radiology panel.
What Does the ACR Guideline for Management of Acute Pulmonary Embolism Cover?
This ACR Appropriateness Criteria document focuses on the initial therapeutic management of adult patients with a confirmed diagnosis of acute pulmonary embolism. The recommendations are stratified based on clinical risk, including hemodynamic stability, evidence of right ventricular (RV) strain, and specific patient contraindications. The scenarios address the spectrum from low-risk PE to submassive and massive PE, guiding the selection of therapies ranging from standard anticoagulation to advanced interventions.
The guideline specifically covers:
- Massive PE with sustained hypotension.
- Submassive PE with evidence of RV strain (e.g., RV/LV ratio > 0.9, elevated troponins).
- Low-risk PE without hypotension or RV strain.
- Special circumstances, such as saddle embolus, thrombus-in-transit, and PE in patients with absolute contraindications to anticoagulation (e.g., intracranial hemorrhage).
This document does not cover the diagnostic workup of suspected PE, management of chronic thromboembolic pulmonary hypertension (CTEPH), or long-term anticoagulation strategies beyond the acute phase. It is intended to guide immediate therapeutic decisions after the diagnosis is established.
What Interventions Should I Consider for Management of Acute Pulmonary Embolism? Recommendations by Clinical Scenario
The appropriate management for acute PE is dictated by the patient’s risk stratification. The ACR provides clear, scenario-based recommendations to guide therapy selection.
For an adult with extensive acute bilateral central pulmonary emboli and sustained hypotension (massive PE), the situation is critical and requires immediate intervention to restore perfusion. The ACR rates several advanced therapies as Usually appropriate, including Systemic thrombolysis, Catheter-directed therapy, and Surgical embolectomy. Standard Anticoagulation is also Usually appropriate as a foundational therapy. Extracorporeal membrane oxygenation (ECMO) is considered May be appropriate as a bridge or rescue therapy in cases of refractory shock.
In the case of a submassive PE—defined as acute bilateral emboli with an RV/LV ratio greater than 0.9, right heart strain on echo, and elevated troponin, but no hypotension—the management strategy shifts. Here, Anticoagulation remains Usually appropriate as the primary treatment. For patients showing signs of clinical deterioration, Catheter-directed therapy is also Usually appropriate. However, Systemic thrombolysis is rated Usually not appropriate due to its higher risk of major bleeding in hemodynamically stable patients. Surgical embolectomy is rated May be appropriate (Disagreement), reflecting its use in select centers for specific high-risk submassive PE patients.
For patients with low-risk PE—characterized by an RV/LV ratio less than 0.9, no right heart strain, and normal troponins—the ACR guidance is straightforward. Anticoagulation alone is Usually appropriate. Advanced interventions like Catheter-directed therapy, Systemic thrombolysis, and Surgical embolectomy are all rated Usually not appropriate, as their risks far outweigh the benefits in this stable population. This holds true even for a saddle pulmonary embolism if the patient is hemodynamically stable with no evidence of RV strain.
A particularly challenging scenario involves a patient with acute PE and right heart failure who has an absolute contraindication to anticoagulation, such as an acute intracranial hemorrhage. In this case, systemic thrombolysis is Usually not appropriate. Catheter-directed therapy becomes Usually appropriate as a primary intervention. Surgical embolectomy is rated May be appropriate (Disagreement), and ECMO is May be appropriate as a supportive measure. Even standard Anticoagulation is downgraded to May be appropriate, reflecting the high-risk balance between thrombosis and bleeding.
Finally, for an adult with an acute thromboembolism in transit (thrombus in the right atrium) and sustained hypotension, urgent intervention is warranted. The ACR rates Catheter-directed therapy, Surgical embolectomy, and Anticoagulation as Usually appropriate. Systemic thrombolysis and ECMO are considered May be appropriate.
ACR Intervention Recommendations Table for Acute Pulmonary Embolism
| Clinical Scenario | Top-Rated Procedures | ACR Rating | Adult RRL | Pediatric RRL |
|---|---|---|---|---|
| Adult. Extensive acute bilateral central PE. Sustained hypotension. | Anticoagulation, Systemic thrombolysis, Catheter-directed therapy, Surgical embolectomy | Usually appropriate | ||
| Adult. Acute bilateral PE. RV/LV ratio > 0.9, right heart strain, elevated troponin. No hypotension. | Anticoagulation, Catheter-directed therapy | Usually appropriate | ||
| Adult. Acute bilateral PE. RV/LV ratio < 0.9, no right heart strain, normal troponin. No hypotension. | Anticoagulation | Usually appropriate | ||
| Adult. Acute saddle PE. Normal RV/LV ratio, normal troponin. No hypotension. | Anticoagulation | Usually appropriate | ||
| Adult. Acute bilateral central PE, right heart failure, and acute intracranial hemorrhage. | Catheter-directed therapy | Usually appropriate | ||
| Adult. Acute thromboembolism in transit (right atrium). Sustained hypotension. | Anticoagulation, Catheter-directed therapy, Surgical embolectomy | Usually appropriate |
Adult vs. Pediatric Considerations in Acute Pulmonary Embolism Management
The current ACR Appropriateness Criteria for the Management of Acute Pulmonary Embolism focus exclusively on adult presentations. All variants provided by the Interventional Radiology panel are for adult patients, and as such, no specific pediatric recommendations or relative radiation level (RRL) estimates are included. This reflects the different epidemiology and treatment considerations for PE in children.
While the diagnostic imaging for PE, such as CT angiography, involves ionizing radiation, the therapeutic procedures discussed here (e.g., catheter-directed therapy, surgical embolectomy) are primarily guided by fluoroscopy. Radiation exposure during these interventions is a key consideration in any patient, but especially in children, where the principle of As Low As Reasonably Achievable (ALARA) is paramount. Pediatric interventional protocols are optimized to minimize radiation dose through techniques like pulsed fluoroscopy, collimation, and reduced frame rates. Should a pediatric patient require such an intervention, it should be performed at a center with specialized pediatric interventional radiology expertise to ensure both safety and efficacy.
Imaging Protocol Details for Management of Acute Pulmonary Embolism
While this document guides therapeutic selection, the initial diagnosis of PE relies on high-quality imaging. The specific technique used to acquire and interpret these studies is critical for accurate risk stratification, which in turn drives management decisions. Our protocol guides provide detailed, practical information on technique, contrast administration, and interpretation principles for the key diagnostic studies used in PE.
Tools to Help You Select the Right Intervention
Navigating complex clinical guidelines during a medical emergency can be challenging. GigHz provides a suite of tools designed to support evidence-based clinical decision-making at the point of care, helping you apply these criteria accurately and efficiently.
The ACR Appropriateness Criteria Lookup allows you to quickly search the complete ACR guidelines for thousands of clinical scenarios beyond acute PE, ensuring you can find the right imaging test for any presentation. For trainees and practicing radiologists, GigHz Precision AI can help streamline the creation of structured, actionable reports for studies like CTAs, ensuring key findings like RV/LV ratio are clearly communicated.
Once an imaging study is chosen, the Imaging Protocol Library offers detailed, step-by-step protocols for performing the study correctly. To help with patient communication regarding radiation exposure from diagnostic scans, the Radiation Dose Calculator provides a straightforward way to estimate and track cumulative radiation dose.
What is the difference between massive and submassive pulmonary embolism?
The primary distinction is hemodynamic stability. A massive PE is defined by sustained hypotension (systolic blood pressure <90 mmHg for >15 minutes), pulselessness, or persistent profound bradycardia. A submassive PE, in contrast, occurs in a normotensive patient but is characterized by evidence of right ventricular dysfunction or myocardial necrosis (e.g., RV dilation on CT/echo, elevated BNP, or elevated troponin).
Why is systemic thrombolysis ‘Usually not appropriate’ for submassive PE?
In hemodynamically stable patients with submassive PE, the risk of major bleeding (including intracranial hemorrhage) associated with full-dose systemic thrombolysis often outweighs the potential benefit. Catheter-directed therapies, which use lower doses of thrombolytic agents delivered directly to the clot, or anticoagulation alone are generally preferred to mitigate this risk.
When should surgical embolectomy be considered?
Surgical embolectomy is typically reserved for patients with massive or high-risk submassive PE in whom thrombolysis is contraindicated (e.g., recent major surgery, trauma, or intracranial hemorrhage) or has failed. It is also a primary option for patients with large, central emboli or thrombus-in-transit that is amenable to surgical removal. The decision requires a multidisciplinary team and is often dependent on institutional expertise.
Is a saddle embolus always a massive PE?
No. While a saddle embolus, which lodges at the bifurcation of the main pulmonary artery, can be large, its clinical classification depends entirely on the patient’s hemodynamic status and RV function. A patient with a saddle PE who is normotensive and has no signs of RV strain is considered to have a low-risk PE and is typically managed with anticoagulation alone.
What is catheter-directed therapy for PE?
Catheter-directed therapy is a minimally invasive procedure performed by an interventional radiologist. It involves advancing a catheter through the veins into the pulmonary arteries directly to the site of the clot. Through the catheter, physicians can administer low-dose thrombolytic drugs (catheter-directed thrombolysis) and/or use devices to mechanically break up and aspirate the clot (mechanical or pharmacomechanical thrombectomy).
What is the role of ECMO in managing acute PE?
Extracorporeal membrane oxygenation (ECMO) is a form of life support that provides cardiac and respiratory support to patients whose heart and lungs are unable to function adequately. In massive PE, ECMO can be used as a bridge to recovery or definitive therapy (like catheter-directed therapy or surgery) by stabilizing a patient in profound cardiogenic shock or cardiac arrest, allowing time for the primary intervention to work.
Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 12, 2026
